In a groundbreaking move for the Indian biotech industry, IXP, a venture capital firm focused on life sciences, has launched its very first fund, the IXP Lifesciences Catalyst Fund. With an ambitious ₹200 crore target, this fund will be investing in early-stage biotech startups that are working on cutting-edge innovations in healthcare, biotechnology, pharmaceuticals, and more. But that’s not…
Fibroheal Woundcare, an innovative startup that is pioneering the use of Silk proteins for wound care, has successfully raised Rs 6.3 crore in a pre-Series A funding round. This significant investment is expected to accelerate the company’s growth and bring cutting-edge wound management solutions to more hospitals and patients across India. Fibroheal’s unique approach to wound care, using…
India IVF, one of the country’s pioneering tech-enabled fertility platforms, has successfully raised $1.25 million in its pre-Series A funding round. The funding, led by Tomorrow Capital, will help the startup expand its network and make fertility care more accessible to underserved communities across North India.
Founded by Dr. Richika Sahay and Dr. Somendra Shukla in 2014, India IVF has been…
